Grant Bishop

Tuesday, 10 November 2026 · Markets closed · Edition 20

Stryker

SYK

Stryker makes surgical equipment, orthopedic implants and medical devices that it sells to hospitals. We follow it because its business sits among the companies whose care and services the new weight-loss drugs may change.

Checked against the company's own business description in its latest annual filing. · entry updated 2026-10-19
Ticker
SYK
Exchange
—
Price
—
Change
—
As of
—
Market cap
—
EV/EBIT
—
P/E NTM
—
FCF yield
—
Net debt/EBITDA
—
Next earnings
—

Last refreshed from 10-Q filed (EDGAR)

Follow · Add to calendar · Daily window

The living report

Bears on our standing view that AI's economy-wide productivity lift does not arrive before 2028. It is proved wrong if productivity jumps much sooner than we expect, or adoption stops spreading.

last revised 19 Oct 2026 · next scheduled disclosure not yet announced
The full report

Members: queues this company for a report on a coming night.

The market record

Free during the preview. Each figure shows only where two independent data providers, Massive and Yahoo, agree on it to the cent; a figure they do not agree on is left out. Dated, not live. It describes; it does not recommend.

Last close$325.73
close of 9 Nov 2026 · Massive and Yahoo agree
The day's range$324.66 – $330.33
9 Nov 2026 · both providers agree
52-week range$267.00 – $389.33
intraday low 11 Sep 2026 · intraday high 2 Mar 2026 · 251 sessions to 9 Nov 2026 · both providers agree
Market value$124.0 billion
the 9 Nov 2026 close × 380,691,004 shares outstanding on the 10-Q cover, as of 30 Sep 2026
$

Enter any price. The page shows the multiple on the forward estimate on file and where that price sits in the 52-week range. It computes; it does not recommend.

Filings

Newest first, from EDGAR. Where a piece read a filing, one line of what it said.

9 Nov 20268-K · period ending 3 Nov 2026
30 Oct 202610-Q · period ending 30 Sep 2026
29 Oct 20268-K · period ending 29 Oct 2026
6 Oct 20268-K · period ending 6 Oct 2026
31 Jul 202610-Q · period ending 30 Jun 2026
30 Jul 20268-K · period ending 30 Jul 2026
26 Jun 20268-K · period ending 26 Jun 2026
20 May 20268-K · period ending 15 May 2026
11 May 202610-Q · period ending 31 Mar 2026
8 May 20268-K · period ending 6 May 2026
30 Apr 20268-K · period ending 30 Apr 2026
9 Apr 20268-K/A · period ending 11 Mar 2026
23 Mar 20268-K · period ending 23 Mar 2026
12 Mar 20268-K · period ending 12 Mar 2026
11 Mar 20268-K · period ending 11 Mar 2026
11 Feb 202610-K · period ending 31 Dec 2025
29 Jan 20268-K · period ending 29 Jan 2026
4 Dec 20258-K · period ending 4 Dec 2025
31 Oct 202510-Q · period ending 30 Sep 2025
30 Oct 20258-K · period ending 30 Oct 2025
1 Aug 202510-Q · period ending 30 Jun 2025
31 Jul 20258-K · period ending 31 Jul 2025
13 May 20258-K · period ending 8 May 2025
2 May 202510-Q · period ending 31 Mar 2025
1 May 20258-K · period ending 1 May 2025
27 Feb 20258-K · period ending 25 Feb 2025
19 Feb 20258-K · period ending 19 Feb 2025
12 Feb 202510-K · period ending 31 Dec 2024
10 Feb 20258-K · period ending 4 Feb 2025
10 Feb 20258-K · period ending 10 Feb 2025
28 Jan 20258-K · period ending 24 Jan 2025
28 Jan 20258-K · period ending 28 Jan 2025
7 Jan 20258-K · period ending 6 Jan 2025

Where it sits in the frame

Reports next

not yet announced

Latest disclosed

10-Q · filed 2026-07-31 · period ending 2026-06-30

Read the filing

Machine-readable

/index/SYK.json

What it has disclosed

Newest first. Every figure traces to a filing; "Show sources" shows which.

—No figure from this company appears in a committed piece yet.

Mentioned in

Every piece that names this company, newest first: what it said, and the standing view it bore on. Written when the piece is committed; never edited, never removed.

—No piece names this company yet.

Same question

Other companies under Whose care and services may the drugs change?

This entry

19 Oct 2026Entry rewritten in plain words: what the company sells, and why we follow it.
12 Oct 2026Verified against the 10-Q filed 2026-07-31 at launch.

Prices on this page are dated market records, shown free during the preview, each confirmed by two independent data providers. None is a recommendation.

Follow Stryker. The weekly piece, and a note when a filing moves it.

Record

Written according to the Grant Bishop standard — machine-researched, machine-checked, human-judged; then read and committed by the publisher. Every number traces to a filing or a dated market record; every claim carries a date and what would prove it wrong.

Verification
multi-source verified, machine-drafted, human-gated
As of
2026-07-31
Position disclosure
The publisher holds index-level U.S. equity exposure and no direct position in any single name discussed.
Not advice
General commentary for a general audience. Not advice for your situation.
Sources (12)